// App-Quantinova.ai

P057 : Immunosuppression doubles the risk of COVID-19 infection in a large vaccinated cohort of 898 patients with rheumatic diseases: implications for future practice

Researchers

Presenter

  • Natasha Cox

Principal Investigators

  • James Bateman

Medical Centers

  • Department of Haematology, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom

  • School of Medicine, Keele University, Keele, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • SJ8903

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved